^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    PLEKHA4 underexpression

    i
    Other names: Pleckstrin Homology Domain Containing A4, PEPP1, Pleckstrin Homology Domain-Containing Family A Member 4, PH Domain-Containing Family A Member 4, Pleckstrin Homology Domain-Containing, Family A (Phosphoinositide Binding Specific) Member 4, Pleckstrin Homology Domain Containing, Family A (Phosphoinositide Binding Specific) Member 4, Phosphoinositol 3-Phosphate-Binding PH Domain Protein 1, Phosphoinositol 3-Phosphate-Binding Protein 1, PLEKHA4, PEPP-1
    Entrez ID:
    57664
    over1year
    Prognostic value of PLEKHA4 and its correlation with tumor-infiltrating immune cells in breast cancer: a comprehensive study based on bioinformatics and clinical analysis validation. (PubMed, Transl Cancer Res)
    The findings indicate that PLEKHA4 is an independent prognostic biomarker associated with key signaling pathways and immune infiltration in BC. Targeting PLEKHA4 may contribute to improving immunotherapy for BC.
    Journal • IO biomarker • Immune cell
    |
    CD8 (cluster of differentiation 8) • PLEKHA4 (Pleckstrin Homology Domain Containing A4)
    |
    PLEKHA4 underexpression